Skip to content
★ Sign in to follow
PB

Peter Bains

Mereo BioPharma Group plc
Total declarations
4
Company
1
▲ Purchases (2 ops.)
€52k
▼ Sales (0 ops.)
—

Latest filing published 24 Jul 2019 for Mereo BioPharma Group plc.

Filing timeline

BuySale
Peter Bains

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-11.9%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Peter Bains: trading record in brief

Peter Bains appears in our data through filings on Mereo BioPharma Group plc shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 21 May 2019 to 24 July 2019.

Every open-market trade on record is a purchase: 2 purchases worth €52k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants.

The record was last updated on 24 July 2019 with a share grant in Mereo BioPharma Group plc. The last insider purchase was made public on 23 May 2019, 2,727 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Peter Bains

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◆
    DirectorExecutivesMereo BioPharma Group plc
    0FCA-NSM
    5,500 sharesOutside of a trading venueFCA-NSM:LSE20190724100812_14161287_20200326185123408_10441-8
  • ▲
    DirectorExecutivesMereo BioPharma Group plc
    42,750 GBP37FCA-NSM
    47,500 shares@ £0.9093.4% of flowAIMXFCA-NSM:LSE20190523161135_14085741_20200326185141891_8374-0
    Canonical exit: 19 Aug 2019 (T+90)
  • ▲
    DirectorExecutivesMereo BioPharma Group plc
    3,828 USD30FCA-NSM
    778 shares@ US$4.926.6% of flowXNMSFCA-NSM:LSE20190523161135_14085741_20200326185141891_8374-1
    Canonical exit: 19 Aug 2019 (T+90)
  • ◆
    DirectorExecutivesMereo BioPharma Group plc
    0FCA-NSM
    5,500 sharesOutside of a trading venueFCA-NSM:LSE20190521150839_14082298_20200326185142080_11482-8

4 of 4 declarations